Nachrichten zur DexCom Inc. Aktie

DexCom Q2 Earnings: Traditional Market Overreaction

…

DXCM FRAUD NOTICE: Lose Money on Your DexCom, Inc. Investment? BFA Law is Investigating the Company for Securities Fraud and Urges You to Contact the Firm (NASDAQ:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…

Bragar Eagel & Squire, P.C. Is Investigating Nano Nuclear, Iris Energy, Ford, and DexCom and Encourages Investors to Contact the Firm

NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

DXCM STOCK NOTICE: DexCom, Inc. is being Investigated for Securities Fraud by BFA Law; Shareholders that Lost Money are Urged to Contact the Firm (NASDAQ:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…

Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally

Recently, weight loss and diabetes watch company DexCom Inc. (NASDAQ: DXCM) stock plummeted by over 44% on a surprisingly bad…

Edelson Lechtzin LLP Announces Investigation of Potential Securities Fraud Claims Against Dexcom, Inc. (NASDAQ: DXCM)

NEWTOWN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a leading class action law firm, is…

DexCom: Anlagevotum bestätigt

St. Petersburg (www.aktiencheck.de) - Rating-Update: Raymond James bewertet die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol: DXCM)…

DexCom: Kursziel reduziert

St. Louis (www.aktiencheck.de) - Rating-Update: Die Analysten von Stifel stufen die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4,…

DexCom Stock Plunged Over 40% Last Week. Are Eli Lillys and Novo Nordisks Drugs to Blame?

DexCom faces several challenges, but GLP-1 drugs arent big problems for the company right now.…

DexCom Stock Plunged Over 40% Last Week. Are Eli Lillys and Novo Nordisks Drugs to Blame? @themotleyfool #stocks $DXCM $VRTX $NVO $LLY

DexCom faces several challenges, but GLP-1 drugs arent big problems for the company right now.…

DexCom: Kurszielsenkung

New York (www.aktiencheck.de) - Rating-Update: Morgan Stanley stuft die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol: DXCM)…

DexCom Aktie: Diabetestechnologie erreicht neuen Meilenstein

In einem bedeutenden Fortschritt für die Diabetesbehandlung wurde kürzlich eine neue Softwareintegration für Insulinpumpen zugelassen. Diese ermöglicht die Kompatibilität mit…

DexCom: Kursziel um 68 USD angepasst

Zürich (www.aktiencheck.de) - Rating-Update: Die Analysten der UBS stufen die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol:…

Stocks making the biggest moves midday: Walt Disney, DexCom, McDonalds, On Semiconductor and more

These are the stocks posting the largest moves in midday trading.…

DexCom Aktie: Umsatzprognose trübt Anlegerstimmung

Die DexCom-Aktie verzeichnete einen deutlichen Rückgang, nachdem das Unternehmen seine Umsatzprognose für das Gesamtjahr 2024 nach unten korrigierte. Trotz eines…

DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of DexCom Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

Stocks rise, Newell Brands stock, energy investing: Market Domination

Today on Market Domination, hosts Josh Lipton and Julie Hyman delve into economic data, trending tickers, and investment strategies. The…

Are GLP-1 drugs creating headwinds for medical device makers?

DexCom (DXCM), the maker of glucose monitoring systems for diabetics, is seeing a major decline in its stock price on…

DexCom stock falls on downgrades, guidance cut (NASDAQ:DXCM)

DexCom (DXCM) stock plunged to a four-year low as Wall Street downgraded the company after its decision to slash the…

DexCom: Enttäuschende Umsatzentwicklung rechtfertigt den 40% Abverkauf nicht - Aktienanalyse

Toronto (www.aktiencheck.de) - DexCom-Aktienanalyse von RBC Capital Markets: Die Analysten vom Investmenthaus RBC Capital Markets stufen die Aktie von DexCom Inc.…

Stocks making the biggest moves midday: 3M, Dexcom, Sweetgreen, Texas Roadhouse and more

These are the stocks posting the largest moves in midday trading.…

Dexcom shares plunge more than 40%, head for worst day on record

Dexcom, which had its stock market debut in 2005, is headed for its worst day ever after lowering its full-year…

Dexcom stock drops 40% after reporting CGM sales challenges

Dexcom’s stock slid by about 40% following its second-quarter earnings report, after the diabetes sensor maker said it saw not…

DexCom slashes full-year sales forecast, shares plummet

DexCom Inc (NASDAQ:DXCM, ETR:DC4), a medical device maker that produces continuous glucose monitoring systems for diabetes management, shares plunged by...…

Blitz-Update USA: Indizes fein aufwärts – Chip-Werte gesucht, 3M an Dow-Spitze, DexCom kollabiert

Zum Wochenende hin berappeln sich viele US-Aktien. Nach einer schwachen Woche zeigen vor allem US-Technologiewerte Erholungs-Tendenz. Der Nasdaq 100 nähert…

DexCom: Enttäuschende Q2-Ergebnisse - Aktienanalyse

New York (www.aktiencheck.de) - DexCom-Aktienanalyse von Oppenheimer: Steven Lichtman, Analyst von Oppenheimer, senkt in einer aktuellen Aktienanalyse das Kursziel für die…

DexCom stock plummets on revenue miss. Are GLP-1s a headwind?

DexCom (DXCM) stock plummets Friday morning — carrying into the market open — after missing second quarter revenue estimates and…

Stocks making the biggest moves premarket: Coursera, WW International, DexCom, Deckers and more

These are the stocks posting the largest moves in premarket trading.…

Bristol-Myers, 3M and Deckers rise premarket; Dexcom falls By Investing.com

Bristol-Myers, 3M and Deckers rise premarket; Dexcom falls…

DexCom-Aktie bricht um ein Drittel ein! Aktienanalyse

Kulmbach (www.aktiencheck.de) - DexCom-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

DexCom-Aktie crasht: Das ist der Grund

Der amerikanische Spezialist für Glukose-Monitoring-Systeme hat am Donnerstag nach US-Börsenschluss für lange Gesichter gesorgt. Das Papier von DexCom bricht nach…

DexCom Q2: Surprising Earnings Miss With Hints Of Competitive Pressures

…

DexCom (DXCM) Q2 2024 Earnings Call Transcript

DXCM earnings call for the period ending June 30, 2024.…

DexCom, Inc. (DXCM) Q2 2024 Earnings Call Transcript

…

DexComs (DXCM) Q2 Earnings Beat Estimates, Revenues Miss

DexComs (DXCM) second-quarter 2024 earnings surpass expectations while revenues fall short. The Sensor segment and CGM system expansion drive growth.…

Dexcom shares plunge after it cuts annual revenue forecast By Reuters

Dexcom shares plunge after it cuts annual revenue forecast…

Dexcom shares plummet almost 40% after company misses on revenue, lowers guidance

Dexcom issued disappointing results and guidance, which the company attributed in part to a change in its salesforce.…

After-hours movers: DexCom, Skechers, Deckers Brands, and more By Investing.com

After-hours movers: DexCom, Skechers, Deckers Brands, and more…

Dexcom cuts guidance as Q2 revenue falls short of estimates; shares slump By Investing.com

Dexcom cuts guidance as Q2 revenue falls short of estimates; shares slump…

CGM Sensor Demand Likely to Drive DexCom (DXCM) Q2 Earnings

DexComs (DXCM) second-quarter 2024 results are likely to reflect rising volumes across all channels.…

The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific

DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific are included in this Analyst Blog.…

DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs

Dexcom (DXCM) and Abbott are set to launch their first FDA-approved over-the-counter CGMs, Stelo and Lingo & Libre Rio, respectively,…

DexComs ADA Conference Takeaways: Stelo, CGM Tailwinds Still Intact

…

DexCom Aktie: Fortschritt im Diabetesmanagement

DexCom Inc. hat in den Niederlanden den Durchbruch für Kinder mit Typ-1-Diabetes erzielt, indem es sein Dexcom G6 Kontinuierliches Glukose-Monitoring…

DexCom Aktie: Diabetesmanagement revolutioniert

DexCom, der Pionier in der Glukoseüberwachungstechnologie, ermöglicht im Verbund mit dem Omnipod® 5 Automated Insulin Delivery (AID) System jetzt auch…

DexComs (DXCM) G6 CGM System Combines With AID in Netherlands

DexCom (DXCM) announces expansion of its AID partnership in the Netherlands to offer an easier diabetes management experience.…

DexCom Aktie: Wachstumskurs überzeugt

DexCom, ein Unternehmen für medizinische Geräte mit Sitz in San Diego, Kalifornien, konzentriert sich auf die Entwicklung kontinuierlicher Glukoseüberwachungssysteme (CGM),…

DexCom Aktie: Marktposition und Insiderverkäufe

DexCom Inc., ein Spezialist im Bereich der Glukoseüberwachungstechnologie, befindet sich in einer starken Wachstumsphase mit signifikanten technologischen Entwicklungen und der…

DexComs (DXCM) G7 CGM System Now Connects to Apple Watch

DexCom (DXCM) announces the direct connectivity of its G7 CGM system to Apple Watch for users in the United States,…

DexCom Aktie: Fortschritt bei Diabetes-Technologie

EDINBURGH, Schottland - Das Unternehmen für kontinuierliche Glukoseüberwachung DexCom hat kürzlich einen bedeutenden Durchbruch für Typ-2-Diabetes-Patienten (T2D), die Basalinsulin-Injektionen verw...…